English
Insider transactions
EDGARRapid Micro Biosystems, Inc.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-20.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 14 transactions, 277,205 shares
- Sum of shares × price per share: 1,138,003.3033
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–50 of 59
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-24 Filed 2026-07-24 | Kollender Richard S Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 1,681 | 0.75 | 1,260.75Derived: shares × price per share. Exact value 1260.75. | 131,999 | Direct (D) | No | — | Open filing 0001415666-26-000008 Read from the filing’s XML Dispute this row |
| 2026-07-24 Filed 2026-07-24 | Kollender Richard S Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 1,827 | 0.75 | 1,370.25Derived: shares × price per share. Exact value 1370.25. | 133,826 | Direct (D) | No | — | Open filing 0001415666-26-000008 Read from the filing’s XML Dispute this row |
| 2026-07-24 Filed 2026-07-24 | Kollender Richard S Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 1,681 | 0 | — | 0 | Direct (D) | No | F1
| Open filing 0001415666-26-000008 Read from the filing’s XML Dispute this row |
| 2026-07-24 Filed 2026-07-24 | Kollender Richard S Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 1,827 | 0 | — | 0 | Direct (D) | No | F1
| Open filing 0001415666-26-000008 Read from the filing’s XML Dispute this row |
| 2026-07-22 Filed 2026-07-24 | Spignesi Robert G. Jr. Director · Officer: PRESIDENT AND CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 1,402 | 0.75 | 1,051.5Derived: shares × price per share. Exact value 1051.50. | 1,191,973 | Direct (D) | No | — | Open filing 0001853904-26-000020 Read from the filing’s XML Dispute this row |
| 2026-07-22 Filed 2026-07-24 | Spignesi Robert G. Jr. Director · Officer: PRESIDENT AND CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 1,402 | 0 | — | 0 | Direct (D) | No | F1
| Open filing 0001853904-26-000020 Read from the filing’s XML Dispute this row |
| 2026-05-29 Filed 2026-06-02 | Spignesi Robert G. Jr. Director · Officer: PRESIDENT AND CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 12,787 | 1.955 | 24,998.585Derived: shares × price per share. Exact value 24998.585. | 1,190,571 | Direct (D) | No | F1, F2
| Open filing 0001853904-26-000017 Read from the filing’s XML Dispute this row |
| 2026-05-29 Filed 2026-06-02 | Spignesi Robert G. Jr. Director · Officer: PRESIDENT AND CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 12,787 | 0 | — | 12,787 | Direct (D) | No | F1, F3
| Open filing 0001853904-26-000017 Read from the filing’s XML Dispute this row |
| 2026-05-29 Filed 2026-06-02 | Spignesi Robert G. Jr. Director · Officer: PRESIDENT AND CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 12,787 | 0 | — | 12,787 | Direct (D) | No | F1, F3
| Open filing 0001853904-26-000017 Read from the filing’s XML Dispute this row |
| 2026-05-29 Filed 2026-06-02 | WIRTJES SEAN M Officer: CHIEF FINANCIAL OFFICER | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 12,787 | 1.955 | 24,998.585Derived: shares × price per share. Exact value 24998.585. | 568,981 | Direct (D) | No | F1
| Open filing 0001289733-26-000014 Read from the filing’s XML Dispute this row |
| 2026-05-29 Filed 2026-06-02 | WIRTJES SEAN M Officer: CHIEF FINANCIAL OFFICER | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 12,787 | 0 | — | 12,787 | Direct (D) | No | F1, F2
| Open filing 0001289733-26-000014 Read from the filing’s XML Dispute this row |
| 2026-05-29 Filed 2026-06-02 | WIRTJES SEAN M Officer: CHIEF FINANCIAL OFFICER | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 12,787 | 0 | — | 12,787 | Direct (D) | No | F1, F2
| Open filing 0001289733-26-000014 Read from the filing’s XML Dispute this row |
| 2026-05-29 Filed 2026-06-02 | Malloy Kirk Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 12,787 | 1.955 | 24,998.585Derived: shares × price per share. Exact value 24998.585. | 60,687 | Direct (D) | No | F1
| Open filing 0001326794-26-000007 Read from the filing’s XML Dispute this row |
| 2026-05-29 Filed 2026-06-02 | Malloy Kirk Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 12,787 | 0 | — | 12,787 | Direct (D) | No | F1, F3
| Open filing 0001326794-26-000007 Read from the filing’s XML Dispute this row |
| 2026-05-29 Filed 2026-06-02 | Malloy Kirk Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 12,787 | 0 | — | 12,787 | Direct (D) | No | F1, F3
| Open filing 0001326794-26-000007 Read from the filing’s XML Dispute this row |
| 2026-05-29 Filed 2026-06-02 | PEI MELINDA LITHERLAND Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 12,787 | 1.955 | 24,998.585Derived: shares × price per share. Exact value 24998.585. | 100,687 | Direct (D) | No | F1
| Open filing 0001703469-26-000010 Read from the filing’s XML Dispute this row |
| 2026-05-29 Filed 2026-06-02 | PEI MELINDA LITHERLAND Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 12,787 | 0 | — | 12,787 | Direct (D) | No | F1, F2
| Open filing 0001703469-26-000010 Read from the filing’s XML Dispute this row |
| 2026-05-29 Filed 2026-06-02 | PEI MELINDA LITHERLAND Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 12,787 | 0 | — | 12,787 | Direct (D) | No | F1, F2
| Open filing 0001703469-26-000010 Read from the filing’s XML Dispute this row |
| 2026-05-29 Filed 2026-06-02 | LOWENSTEIN INESE Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 12,787 | 1.955 | 24,998.585Derived: shares × price per share. Exact value 24998.585. | 70,687 | Direct (D) | No | F1
| Open filing 0001900476-26-000008 Read from the filing’s XML Dispute this row |
| 2026-05-29 Filed 2026-06-02 | LOWENSTEIN INESE Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 12,787 | 0 | — | 12,787 | Direct (D) | No | F1, F2
| Open filing 0001900476-26-000008 Read from the filing’s XML Dispute this row |
| 2026-05-29 Filed 2026-06-02 | LOWENSTEIN INESE Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 12,787 | 0 | — | 12,787 | Direct (D) | No | F1, F2
| Open filing 0001900476-26-000008 Read from the filing’s XML Dispute this row |
| 2026-05-21 Filed 2026-05-26 | PEI MELINDA LITHERLAND Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 19,300 | 0 | — | 87,900 | Direct (D) | No | F1
| Open filing 0001703469-26-000007 Read from the filing’s XML Dispute this row |
| 2026-05-21 Filed 2026-05-26 | PEI MELINDA LITHERLAND Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 38,700 | 0 | — | 38,700 | Direct (D) | No | F2
| Open filing 0001703469-26-000007 Read from the filing’s XML Dispute this row |
| 2026-05-21 Filed 2026-05-26 | Bika Dafni Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 19,300 | 0 | — | 19,300 | Direct (D) | No | F1
| Open filing 0002070373-26-000003 Read from the filing’s XML Dispute this row |
| 2026-05-21 Filed 2026-05-26 | Bika Dafni Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 38,700 | 0 | — | 38,700 | Direct (D) | No | F2
| Open filing 0002070373-26-000003 Read from the filing’s XML Dispute this row |
| 2026-05-21 Filed 2026-05-26 | Malloy Kirk Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 19,300 | 0 | — | 47,900 | Direct (D) | No | F1
| Open filing 0001326794-26-000003 Read from the filing’s XML Dispute this row |
| 2026-05-21 Filed 2026-05-26 | Malloy Kirk Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 38,700 | 0 | — | 38,700 | Direct (D) | No | F3
| Open filing 0001326794-26-000003 Read from the filing’s XML Dispute this row |
| 2026-05-21 Filed 2026-05-26 | LOWENSTEIN INESE Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 19,300 | 0 | — | 57,900 | Direct (D) | No | F1
| Open filing 0001900476-26-000005 Read from the filing’s XML Dispute this row |
| 2026-05-21 Filed 2026-05-26 | LOWENSTEIN INESE Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 38,700 | 0 | — | 38,700 | Direct (D) | No | F2
| Open filing 0001900476-26-000005 Read from the filing’s XML Dispute this row |
| 2026-05-21 Filed 2026-05-26 | Kollender Richard S Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 19,300 | 0 | — | 130,318 | Direct (D) | No | F1
| Open filing 0001415666-26-000005 Read from the filing’s XML Dispute this row |
| 2026-05-21 Filed 2026-05-26 | Kollender Richard S Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 38,700 | 0 | — | 38,700 | Direct (D) | No | F2
| Open filing 0001415666-26-000005 Read from the filing’s XML Dispute this row |
| 2026-05-20 Filed 2026-05-22 | Bain Capital Life Sciences Investors, LLC 10% ownerBain Capital Life Sciences Partners, LP 10% ownerBain Capital Life Sciences Fund, L.P. 10% ownerBCIP Life Sciences Associates, LP 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 1,463,000 | — | — | 1,463,000 | Indirect (I) See footnotes | No | F1, F2, F3, F6
| Open filing 0001193125-26-237016 Read from the filing’s XML Dispute this row |
| 2026-05-20 Filed 2026-05-22 | Bain Capital Life Sciences Investors, LLC 10% ownerBain Capital Life Sciences Partners, LP 10% ownerBain Capital Life Sciences Fund, L.P. 10% ownerBCIP Life Sciences Associates, LP 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 1,463,000 | — | — | 1,463,000 | Indirect (I) See footnotes | No | F1, F2, F6
| Open filing 0001193125-26-237016 Read from the filing’s XML Dispute this row |
| 2026-05-20 Filed 2026-05-22 | Bain Capital Life Sciences Investors, LLC 10% ownerBain Capital Life Sciences Partners, LP 10% ownerBain Capital Life Sciences Fund, L.P. 10% ownerBCIP Life Sciences Associates, LP 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 1,463,000 | — | — | 1,463,000 | Indirect (I) See footnotes | No | F1, F2, F6
| Open filing 0001193125-26-237016 Read from the filing’s XML Dispute this row |
| 2026-03-11 Filed 2026-03-12 | Wilson John J. Addington Officer: CHIEF OPERATING OFFICER | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 9,603 | 4.3181 | 41,466.7143Derived: shares × price per share. Exact value 41466.7143. | 316,762 | Direct (D) | No | F1
| Open filing 0001872301-26-000012 Read from the filing’s XML Dispute this row |
| 2026-03-11 Filed 2026-03-12 | WIRTJES SEAN M Officer: CHIEF FINANCIAL OFFICER | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 7,480 | 4.3181 | 32,299.388Derived: shares × price per share. Exact value 32299.3880. | 556,194 | Direct (D) | No | F1
| Open filing 0001289733-26-000011 Read from the filing’s XML Dispute this row |
| 2026-03-10 Filed 2026-03-12 | Spignesi Robert G. Jr. Director · Officer: PRESIDENT AND CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 17,922 | 4.1115 | 73,686.303Derived: shares × price per share. Exact value 73686.3030. | 1,169,848 | Direct (D) | No | F1
| Open filing 0001853904-26-000013 Read from the filing’s XML Dispute this row |
| 2026-02-27 Filed 2026-03-02 | RICCIARDI NATALE S Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 842 | 0.75 | 631.5Derived: shares × price per share. Exact value 631.50. | 29,442 | Direct (D) | No | — | Open filing 0001107158-26-000002 Read from the filing’s XML Dispute this row |
| 2026-02-27 Filed 2026-03-02 | RICCIARDI NATALE S Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 842 | 0.75 | 631.5Derived: shares × price per share. Exact value 631.50. | 0 | Direct (D) | No | F1
| Open filing 0001107158-26-000002 Read from the filing’s XML Dispute this row |
| 2026-02-20 Filed 2026-02-20 | WIRTJES SEAN M Officer: CHIEF FINANCIAL OFFICER | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 17,254 | 3.923 | 67,687.442Derived: shares × price per share. Exact value 67687.442. | 563,674 | Direct (D) | No | F1
| Open filing 0001289733-26-000008 Read from the filing’s XML Dispute this row |
| 2026-02-20 Filed 2026-02-20 | Wilson John J. Addington Officer: CHIEF OPERATING OFFICER | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 5,403 | 3.923 | 21,195.969Derived: shares × price per share. Exact value 21195.969. | 326,365 | Direct (D) | No | F1
| Open filing 0001872301-26-000009 Read from the filing’s XML Dispute this row |
| 2026-02-19 Filed 2026-02-20 | Spignesi Robert G. Jr. Director · Officer: PRESIDENT AND CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 38,327 | 3.8853 | 148,911.8931Derived: shares × price per share. Exact value 148911.8931. | 1,187,770 | Direct (D) | No | F1
| Open filing 0001853904-26-000010 Read from the filing’s XML Dispute this row |
| 2026-02-11 Filed 2026-02-13 | Spignesi Robert G. Jr. Director · Officer: PRESIDENT AND CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 264,000 | 0 | — | 1,226,097 | Direct (D) | No | F1
| Open filing 0001380106-26-000013 Read from the filing’s XML Dispute this row |
| 2026-02-11 Filed 2026-02-13 | Spignesi Robert G. Jr. Director · Officer: PRESIDENT AND CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 528,000 | 0 | — | 528,000 | Direct (D) | No | F2
| Open filing 0001380106-26-000013 Read from the filing’s XML Dispute this row |
| 2026-02-11 Filed 2026-02-13 | Wilson John J. Addington Officer: CHIEF OPERATING OFFICER | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 74,000 | 0 | — | 331,768 | Direct (D) | No | F1
| Open filing 0001380106-26-000017 Read from the filing’s XML Dispute this row |
| 2026-02-11 Filed 2026-02-13 | Wilson John J. Addington Officer: CHIEF OPERATING OFFICER | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 147,000 | 0 | — | 147,000 | Direct (D) | No | F2
| Open filing 0001380106-26-000017 Read from the filing’s XML Dispute this row |
| 2026-02-11 Filed 2026-02-13 | WIRTJES SEAN M Officer: CHIEF FINANCIAL OFFICER | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 97,000 | 0 | — | 580,928 | Direct (D) | No | F1
| Open filing 0001380106-26-000015 Read from the filing’s XML Dispute this row |
| 2026-02-11 Filed 2026-02-13 | WIRTJES SEAN M Officer: CHIEF FINANCIAL OFFICER | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 193,000 | 0 | — | 193,000 | Direct (D) | No | F2
| Open filing 0001380106-26-000015 Read from the filing’s XML Dispute this row |
| 2026-02-09 Filed 2026-02-10 | Spignesi Robert G. Jr. Director · Officer: PRESIDENT AND CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 12,840 | 3.7827 | 48,569.868Derived: shares × price per share. Exact value 48569.8680. | 962,097 | Direct (D) | No | F1
| Open filing 0001853904-26-000004 Read from the filing’s XML Dispute this row |
| 2026-02-09 Filed 2026-02-10 | WIRTJES SEAN M Officer: CHIEF FINANCIAL OFFICER | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 6,027 | 3.7827 | 22,798.3329Derived: shares × price per share. Exact value 22798.3329. | 483,928 | Direct (D) | No | F1
| Open filing 0001289733-26-000004 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,925 filings read, the latest filed 2026-11-19. Prior quarter ending 2026-06-30: 9,176 filings read.
Showing 1–39 of 39
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,434,560 SH | 8,687,596 dollars | Unchanged Prior quarter: 8,434,560 | Open filing 0001193125-26-462089 Filed 2026-11-16 Dispute this row |
| ARMISTICE CAPITAL, LLC | 2,017,963 SH | 2,078,502 dollars | Lower by 1,310,037 Prior quarter: 3,328,000 | Open filing 0001315863-26-000784 Filed 2026-11-16 Dispute this row |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 1,848,296 SH | 1,903,745 dollars | Unchanged Prior quarter: 1,848,296 | Open filing 0001193125-26-463671 Filed 2026-11-16 Dispute this row |
| VANGUARD CAPITAL MANAGEMENT LLC | 953,744 SH | 982,356 dollars | Lower by 28,290 Prior quarter: 982,034 | Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row |
| KHAZANAH NASIONAL BERHAD | 566,905 SH | 583,912 dollars | Unchanged Prior quarter: 566,905 | Open filing 0000905148-26-004863 Filed 2026-11-16 Dispute this row |
| GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager | 246,458 SH | 253,969 dollars | Higher by 18,417 Prior quarter: 228,041 | Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row |
| RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager | 239,987 SH | 247,187 dollars | Higher by 27,886 Prior quarter: 212,101 | Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row |
| BlackRock, Inc. Partly reported under another manager | 196,894 SH | 202,801 dollars | Higher by 7,062 Prior quarter: 189,832 | Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row |
| VANGUARD FIDUCIARY TRUST CO | 184,900 SH | 190,447 dollars | Higher by 74,416 Prior quarter: 110,484 | Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row |
| MILLENNIUM MANAGEMENT LLC | 183,034 SH | 188,525 dollars | Lower by 53,565 Prior quarter: 236,599 | Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row |
| CITADEL ADVISORS LLC Partly reported under another manager | 182,361 SH | 187,832 dollars | Higher by 166,219 Prior quarter: 16,142 | Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row |
| Corient Private Wealth LP | 173,719 SH | 178,931 dollars | Not in the prior quarter’s filings read | Open filing 0001948780-26-000012 Filed 2026-11-16 Dispute this row |
| STATE STREET CORP Partly reported under another manager | 93,874 SH | 96,690 dollars | Unchanged Prior quarter: 93,874 | Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row |
| GSA CAPITAL PARTNERS LLP | 79,076 SH | 81 dollars | Not in the prior quarter’s filings read | Open filing 0001362033-26-000013 Filed 2026-11-16 Dispute this row |
| XTX Topco Ltd Partly reported under another manager | 65,036 SH | 66,987 dollars | Lower by 14,691 Prior quarter: 79,727 | Open filing 0001828301-26-000009 Filed 2026-11-16 Dispute this row |
| DIMENSIONAL FUND ADVISORS LP Partly reported under another manager | 63,506 SH | 65,559 dollars | Lower by 40,686 Prior quarter: 104,192 | Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row |
| ACADIAN ASSET MANAGEMENT LLC Partly reported under another manager | 60,005 SH | 60 dollars | Not in the prior quarter’s filings read | Open filing 0001140361-26-042753 Filed 2026-11-09 Dispute this row |
| Squarepoint Ops LLC Partly reported under another manager | 58,359 SH | 60,110 dollars | Not in the prior quarter’s filings read | Open filing 0001642575-26-000012 Filed 2026-11-09 Dispute this row |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP Partly reported under another manager | 49,069 SH | 50,541 dollars | Not in the prior quarter’s filings read | Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row |
| Temasek Holdings (Private) Ltd Partly reported under another manager | 43,636 SH | 44,945 dollars | Not in the prior quarter’s filings read | Open filing 0001021944-26-000015 Filed 2026-10-28 Dispute this row |
| NORTHERN TRUST CORP Partly reported under another manager | 42,106 SH | 43,369 dollars | Unchanged Prior quarter: 42,106 | Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row |
| Pekin Hardy Strauss, Inc. | 40,000 SH | 41,200 dollars | Not in the prior quarter’s filings read | Open filing 0001020317-26-000005 Filed 2026-11-02 Dispute this row |
| FNY Investment Advisers, LLC | 35,000 SH | 36 dollars | Not in the prior quarter’s filings read | Open filing 0001742998-26-000005 Filed 2026-10-16 Dispute this row |
| MORGAN STANLEY Partly reported under another manager | 33,147 SH | 34,141 dollars | Higher by 5,560 Prior quarter: 27,587 | Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row |
| AXQ CAPITAL, LP | 15,796 SH | 16,270 dollars | Not in the prior quarter’s filings read | Open filing 0001420506-26-002583 Filed 2026-11-12 Dispute this row |
| AMERICAN CENTURY COMPANIES INC Partly reported under another manager | 11,638 SH | 11,987 dollars | Unchanged Prior quarter: 11,638 | Open filing 0000748054-26-000008 Filed 2026-11-12 Dispute this row |
| Vanguard Global Advisers, LLC | 11,630 SH | 11,979 dollars | Unchanged Prior quarter: 11,630 | Open filing 0001811242-26-000017 Filed 2026-11-13 Dispute this row |
| GOLDMAN SACHS GROUP INC Partly reported under another manager | 10,870 SH | 11,196 dollars | Not in the prior quarter’s filings read | Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row |
| Wealth Analytics Partners, LLC | 10,000 SH | 10,300 dollars | Not in the prior quarter’s filings read | Open filing 0001214659-26-013040 Filed 2026-10-19 Dispute this row |
| Tower Research Capital LLC (TRC) Partly reported under another manager | 7,302 SH | 7,521 dollars | Higher by 5,402 Prior quarter: 1,900 | Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row |
| DUPONT CAPITAL MANAGEMENT CORP | 3,370 SH | 3,471 dollars | Not in the prior quarter’s filings read | Open filing 0001140361-26-040602 Filed 2026-10-23 Dispute this row |
| UBS Group AG Partly reported under another manager | 2,753 SH | 2,836 dollars | Lower by 3,854 Prior quarter: 6,607 | Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row |
| Nuveen, LLC Partly reported under another manager | 724 SH | 782 dollars | Not in the prior quarter’s filings read | Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row |
| OSAIC HOLDINGS, INC. Partly reported under another manager | 295 SH | 318 dollars | Lower by 14,005 Prior quarter: 14,300 | Open filing 0001677044-26-000011 Filed 2026-11-12 Dispute this row |
| ROYAL BANK OF CANADA Partly reported under another manager | 204 SH | 0 dollars | Not in the prior quarter’s filings read | Open filing 0001140361-26-044123 Filed 2026-11-16 Dispute this row |
| JPMORGAN CHASE CO Partly reported under another manager | 109 SH | 118 dollars | Unchanged Prior quarter: 109 | Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row |
| SBI Securities Co., Ltd. | 30 SH | 31 dollars | Higher by 15 Prior quarter: 15 | Open filing 0001851815-26-000004 Filed 2026-10-22 Dispute this row |
| Caitong International Asset Management Co., Ltd | 21 SH | 22 dollars | Lower by 14 Prior quarter: 35 | Open filing 0001628280-26-068135 Filed 2026-10-29 Dispute this row |
| BARCLAYS PLC Partly reported under another manager | 2 SH | 2 dollars | Lower by 335 Prior quarter: 337 | Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- Evernest Financial Advisors, LLC 506,000 SH
- Advent International, L.P. 379,794 SH
- ESSEX INVESTMENT MANAGEMENT CO LLC 362,696 SH
- SEI INVESTMENTS CO 66,869 SH
- ALGERT GLOBAL LLC 38,307 SH
- JANE STREET GROUP, LLC 25,931 SH
- HRT FINANCIAL LP 23,093 SH
- NANO CAP NEW MILLENNIUM GROWTH FUND L P 12,500 SH
- Larson Financial Group LLC 8,395 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Longitude Capital Partners II, LLC Class A common stock, $0.01 par value per share | 3.3 | 1,514,245 | 10/15/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 3 | Open filing 0001193125-26-464016 Dispute this row |
| Longitude Venture Partners II, L.P. Class A common stock, $0.01 par value per share | 3.3 | 1,514,245 | 10/15/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 3 | Open filing 0001193125-26-464016 Dispute this row |
| Patrick G. Enright Class A common stock, $0.01 par value per share | 3.5 | 1,596,280 | 10/15/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 3 | Open filing 0001193125-26-464016 Dispute this row |
| Juliet Tammenoms Bakker Class A common stock, $0.01 par value per share | 3.5 | 1,579,873 | 10/15/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 3 | Open filing 0001193125-26-464016 Dispute this row |
| Armistice Capital, LLC Class A common stock, $0.01 par value per share | 7.29 | 3,328,000.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G | Open filing 0001172661-26-003614 Dispute this row |
| Steven Boyd Class A common stock, $0.01 par value per share | 7.29 | 3,328,000.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G | Open filing 0001172661-26-003614 Dispute this row |
| Bain Capital Life Sciences Fund, L.P. Class A Common Stock, par value $0.01 per share | 16.76 | 7,651,369 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001193125-26-350331 Dispute this row |
| BCIP Life Sciences Associates, LP Class A Common Stock, par value $0.01 per share | 1.72 | 783,191 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001193125-26-350331 Dispute this row |
| Longitude Capital Partners II, LLC Class A common stock, $0.01 par value per share | 8.6 | 3,529,245 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-227039 Dispute this row |
| Longitude Venture Partners II, L.P. Class A common stock, $0.01 par value per share | 8.6 | 3,529,245 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-227039 Dispute this row |
| Longitude Prime Partners, LLC Class A common stock, $0.01 par value per share | 0 | 0 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-227039 Dispute this row |
| Longitude Prime Fund, L.P. Class A common stock, $0.01 par value per share | 0 | 0 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-227039 Dispute this row |
| Patrick G. Enright Class A common stock, $0.01 par value per share | 8.6 | 3,529,245 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-227039 Dispute this row |
| Juliet Tammenoms Bakker Class A common stock, $0.01 par value per share | 8.6 | 3,529,245 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-227039 Dispute this row |
| Endeavour Medtech Growth II LP Common Stock, par value $0.01 | 5.7 | 2,257,099 | 12/31/2025 Filed 2026-02-13 | SCHEDULE 13G/AAmendment 3 | Open filing 0001193125-26-051663 Dispute this row |
| Endeavour Medtech Growth II Parallel LP Common Stock, par value $0.01 | 5.7 | 2,257,099 | 12/31/2025 Filed 2026-02-13 | SCHEDULE 13G/AAmendment 3 | Open filing 0001193125-26-051663 Dispute this row |
| Endeavour Medtech II GP Limited Common Stock, par value $0.01 | 5.7 | 2,257,099 | 12/31/2025 Filed 2026-02-13 | SCHEDULE 13G/AAmendment 3 | Open filing 0001193125-26-051663 Dispute this row |
| SPIGNESI ROBERT G JR Class A Common Stock, $0.01 par value per share | 6.3 | 2,647,256.00 | 03/28/2024 Filed 2025-08-19 | SCHEDULE 13D | Open filing 0001380106-25-000185 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,598,888 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 17,857 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 224,461 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 263,123 |
Filings made before the SEC required XML are listed, not extracted.